ARCHIVES

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

ASCO Letter To NCI Urges Increased Support for Clinical Trials, Training, Translational Research

March 6, 2009

DeVita Asks Panel’s Assistance On Personnel Ceilings, Construction, New NCAB Appointments

December 9, 1983

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

ACS names new officers.

December 5, 2003

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

Study Links Exercise and Survival In Breast and Colon Cancer Mortality

May 25, 2012